Healthcare / Medical DistributionNYSE
$736.30
+1.48 (+0.20%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 21% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.2B · quality 85.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$88.5B
P/E
19.2x
↓EV/EBITDA
13.4x
↑ROE
-219.2%
↓Gross Margin
3.6%
↓Debt/Equity
-3.97
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2008–2026 · 18 años de histórico normalizado
Revenue CAGR
+8.0%
FCF CAGR
+12.3%
FCF margin
1.3%
FCF / Net income
1.14x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $403.43B · net income $4.76B · FCF $5.41B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $403.43B | $403.43B | $359.05B | $308.95B | $276.71B | $263.97B | $238.23B | $231.05B | $214.32B | $208.36B | $198.53B | $190.88B | $179.04B | $137.39B | $122.20B | $122.32B | $112.08B | $108.70B | $106.63B | $101.70B |
| Net Income | $4.76B | $4.76B | $3.29B | $3.00B | $3.56B | $1.11B | $-4.54B | $900.0M | $34.0M | $67.0M | $5.07B | $2.26B | $1.48B | $1.26B | $1.34B | $1.40B | $1.20B | $1.26B | $823.0M | $990.0M |
| EBITDA | $7.18B | $7.18B | $5.26B | $4.68B | $5.49B | $2.35B | $-4.70B | $2.82B | $1.20B | $1.71B | $8.03B | $4.43B | $3.98B | $3.17B | $2.93B | $2.62B | $2.32B | $2.48B | $1.51B | — |
| EPS | 38.38 | 38.38 | 25.72 | 22.39 | 25.03 | 7.23 | -28.26 | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 | 4.62 | 2.95 | 3.32 |
| Gross Margin | 3.6% | 3.6% | 3.7% | 4.2% | 4.5% | 5.0% | 5.1% | 5.2% | 5.5% | 5.4% | 5.7% | 6.0% | 6.4% | 6.1% | 5.6% | 5.2% | 5.3% | 5.2% | 5.0% | 4.9% |
| Operating Margin | 1.6% | 1.6% | 1.3% | 1.4% | 1.7% | 0.8% | -2.1% | 1.1% | 0.4% | 0.4% | 3.6% | 1.9% | 1.7% | 1.8% | 1.9% | 1.7% | 1.6% | 1.8% | 1.1% | 1.5% |
| Net Margin | 1.2% | 1.2% | 0.9% | 1.0% | 1.3% | 0.4% | -1.9% | 0.4% | 0.0% | 0.0% | 2.6% | 1.2% | 0.8% | 0.9% | 1.1% | 1.1% | 1.1% | 1.2% | 0.8% | 1.0% |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | -3.97 | -3.97 | -3.56 | -3.75 | -3.93 | -2.59 | -340.38 | 1.45 | 0.94 | 0.80 | 0.75 | 0.91 | 1.21 | 1.21 | 0.69 | 0.45 | 0.50 | 0.30 | — | — |
| Current Ratio | 0.85 | 0.85 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | $5.41B | $5.41B | $5.23B | $3.63B | $4.60B | $4.05B | $4.09B | $4.01B | $3.61B | $3.94B | $4.34B | $3.18B | $2.74B | $2.86B | $2.24B | $2.73B | $2.10B | $2.12B | $1.16B | $674.0M |
| Returns | ||||||||||||||||||||
| ROE | -219.2% | -219.2% | -158.9% | -152.3% | -191.7% | -49.0% | 21614.3% | 17.7% | 0.4% | 0.7% | 45.7% | 25.3% | 18.4% | 14.8% | 18.9% | 20.5% | 16.6% | 16.8% | 13.3% | — |
| Valuation | ||||||||||||||||||||
| P/E | 19.19 | 19.19 | 26.56 | 24.06 | 14.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 13.38 | 13.38 | 16.96 | 16.05 | 10.07 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 12.4% | 12.4% | 16.2% | 11.7% | — | 10.8% | 3.1% | 7.8% | 2.9% | 4.9% | 4.0% | 6.6% | 30.3% | 12.4% | -0.1% | 9.1% | 3.1% | 1.9% | 4.8% | — |
| EPS Growth | 49.2% | 49.2% | 14.9% | -10.5% | — | 125.6% | -670.9% | 2811.8% | -46.9% | -98.6% | 134.3% | 54.7% | 15.9% | -3.2% | 0.0% | 22.3% | -1.1% | 56.6% | -11.1% | — |
| Dividend Yield | 0.4% | 0.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.4%
EPS terminal req.
$65.33
Spread vs growth
29.8%
5Y implied EPS CAGR
15.5%
EPS terminal req.
$79.05
Spread vs growth
33.7%
10Y implied EPS CAGR
12.7%
EPS terminal req.
$127.32
Spread vs growth
36.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.5%
Start / end P/E
28.1x → 19.2x
EPS bridge
25.72 → 38.38
Residual
-15.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.